R. Meli et al., PROLACTIN MODULATION OF NITRIC-OXIDE AND TNF-ALPHA PRODUCTION BY PERIPHERAL NEUTROPHILS IN RATS, Life sciences, 61(14), 1997, pp. 1395-1403
Citations number
37
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
It has been demonstrated that prolactin (PRL) is a potent immunomodula
tor that exerts stimulatory effects on physiological responses of immu
ne cells. In the present research we have investigated whether PRL may
influence nitric oxide (NO) and/or tumor necrosis factor-alpha (TNF-a
lpha) production in neutrophils obtained from inflammatory exudate of
carrageenin-induced experimental pleurisy in the rat. In this acute mo
del of inflammation the role of endogenous NO was evaluated using an i
nhibitor of NO-synthase, N-G-nitro-L-arginine methyl ester (L-NAME). A
treatment of animals with L-NAME (10 mg/kg s.c.) induced a reduction
of volume and cell number of pleural exudate and a decrease of nitrite
production (measured by the Griees reaction) by polymorphonuclear cel
ls after 24 h of incubation, while D-NAME, the inactive isomer, was wi
thout effect. Neutrophils from ovine prolactin (oPRL) treated rats (5
mg/kg for 5 times s.c.) or from rats with a hyperprolactinaemia induce
d by pituitary gland graft produced higher amounts of NO both after 24
and 48 h of incubation. On the contrary, a clear reduction in the pro
duction of NO was found in neutrophils from rats treated with bromocri
ptine (BRC) (2 mg/kg s.c.), a dopamine D-2-receptor agonist. TNF-alpha
production (measured by MTT/cytotoxic assay) by neutrophils was marke
dly increased in PRL-treated or pituitary-grafted rats in comparison t
o controls, whereas BRC treatment reduced TNF-alpha production.